Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial
… mmol/L, multiply by 0.0555] or lower with symptoms) hypoglycemic episodes recorded from baseline until week 31. Change in vital signs, electrocardiogram, physical examination, and …..... Read More